NIH-funded research Fellowship grant

Understanding how the history of bacteria affects their resistance to antibiotics

Official title: Using strain history to improve prediction of the evolution of antimicrobial resistance in Acinetobacter baumannii

Funded at University of Pittsburgh at Pittsburgh · NIH-10974013 · Data updated 2026-11-12

This study looks at how the history of a germ called Acinetobacter baumannii affects its ability to resist antibiotics, helping us understand why some infections are harder to treat and how we can better fight them.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Pittsburgh at Pittsburgh
NIH-funded
Lab location1 site (Pittsburgh, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2025
Funding year2024
Award (this year)$48,974
NIH project number5F31AI172279-02
Project IDNIH-10974013 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients who have been infected with Acinetobacter baumannii or are at risk of such infections, particularly those with a history of antibiotic treatment.

Less likely to help

Patients with infections caused by other types of bacteria that do not involve Acinetobacter baumannii may not benefit from this research.

What this research studies

This research investigates how the evolutionary history of Acinetobacter baumannii influences its ability to develop resistance to antibiotics. By analyzing a collection of clinical isolates, the study aims to identify genetic and phenotypic differences that contribute to antimicrobial resistance. The researchers will explore how factors like genetic relatedness and previous antibiotic exposure shape the bacteria's evolution and predictability of resistance. This work is crucial for developing strategies to combat antibiotic-resistant infections.

Why it matters

Potential benefit: If successful, this research could lead to improved predictions of antibiotic resistance patterns, enhancing treatment strategies for patients with infections caused by Acinetobacter baumannii.

How similar studies have gone: Previous research has shown success in understanding antimicrobial resistance through genetic analysis, making this approach promising yet still exploring new aspects of bacterial evolution.

Where this research is happening

  • University of Pittsburgh at Pittsburgh
    Pittsburgh, United States
    Active

Researchers

  • Principal investigator: Rokes, Alecia Barbara — University of Pittsburgh at Pittsburgh
  • Study coordinator: Rokes, Alecia Barbara

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.